Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants ...
Idarucizumab is an antibody fragment specific for the immediate reversal of dabigatran anticoagulation effects. The use of idarucizumab is approved for dabigatran-treated patients suffering from ...
Am J Health Syst Pharm. 2011;68(16):1506-1519. b These values are mean population values based on data from dabigatran doses ranging from 10 to 400 mg given as single and multiple doses.